Key result
In patients with ischemic disease, heart failure was associated with higher iNOS activity compared to non-failing hearts.
Why the study?
Does heart failure due to ischemic disease alter the expression and activity of nitric oxide synthases in cardiac tissue?
Observational (n=20)
Does heart failure due to ischemic disease alter the expression and activity of nitric oxide synthases in cardiac tissue?
Answers are grounded in this paper and cite their sources.
Heart failure due to ischemic disease is associated with down-regulated eNOS and up-regulated iNOS activity and expression in cardiac tissue, suggesting an alternative mechanism for nitric oxide production.
The objective of the present study was to determine the relationship between nitric oxide synthases (NOS) and heart failure in cardiac tissue from patients with and without cardiac decompensation. Right atrial tissue was excised from patients with coronary artery disease (CAD) and left ventricular ejection fraction (LVEF) <35% (N = 10), and from patients with CAD and LVEF >60% (N = 10) during cardiac surgery. NOS activity was measured by the conversion of L-[H(3)]-arginine to L-[H(3)]-citrulline. Gene expression was quantified by the competitive reverse transcription-polymerase chain reaction. Both endothelial NOS (eNOS) activity and expression were significantly reduced in failing hearts compared to non-failing hearts: 0.36 +/- 0.18 vs 1.51 +/- 0.31 pmol mg-1 min-1 (P < 0.0001) and 0.37 +/- 0.08 vs 0.78 +/- 0.09 relative cDNA absorbance at 320 nm (P < 0.0001), respectively. In contrast, inducible NOS (iNOS) activity and expression were significantly higher in failing hearts than in non-failing hearts: 4.00 +/- 0.90 vs 1.54 +/- 0.65 pmol mg-1 min-1 (P < 0.0001) and 2.19 +/- 0.27 vs 1.43 +/- 0.13 cDNA absorbance at 320 nm (P < 0.0001), respectively. We conclude that heart failure down-regulates both eNOS activity and expression in cardiac tissue from patients with LVEF <35%. In contrast, iNOS activity and expression are increased in failing hearts and may represent an alternative mechanism for nitric oxide production in heart failure due to ischemic disease.
No takes yet. Share an insight, caveat, or question.
Ferreiro et al. (2004) conducted an observational in Heart failure due to ischemic disease (n=20). Heart failure (LVEF <35%) vs. Non-failing hearts (LVEF >60%) was evaluated on iNOS activity (pmol mg-1 min-1) (p=< 0.0001). In patients with ischemic disease, heart failure was associated with higher iNOS activity compared to non-failing hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: